Dennis McCarty1, Traci Rieckmann1, Robin L Baker1, K John McConnell1. 1. Dr. McCarty, Dr. Rieckmann, and Ms. Baker are with the Oregon Health and Science University (OHSU)-Portland State University School of Public Health, and Dr. McConnell is with the Department of Emergency Medicine and the Center for Health Systems Effectiveness, OHSU, Portland (e-mail: mccartyd@ohsu.edu ).
Abstract
OBJECTIVE: Title 42 of the Code of Federal Regulations Part 2 (42 CFR Part 2) controls the release of patient information about treatment for substance use disorders. In 2016, the Substance Abuse and Mental Health Services Administration (SAMHSA) released a proposed rule to update the regulations, reduce provider burdens, and facilitate information exchange. Oregon's Medicaid program (Oregon Health Plan) altered the financing and structure of medical, dental, and behavioral care to promote greater integration and coordination. A qualitative analysis examined the perceived impact of 42 CFR Part 2 on care coordination and integration. METHODS: Interviews with 76 stakeholders (114 interviews) conducted in 2012-2015 probed the processes of integrating behavioral health into primary care settings in Oregon and assessed issues associated with adherence to 42 CFR Part 2. RESULTS: Respondents expressed concerns that the regulations caused legal confusion, inhibited communication and information sharing, and required updating. Addiction treatment directors noted the challenges of obtaining patient consent to share information with primary care providers. CONCLUSIONS: The confidentiality regulations were perceived as a barrier to care coordination and integration. The Oregon Health Authority, therefore, requested regulatory changes. SAMHSA's proposed revisions permit a general consent to an entire health care team and allow inclusion of substance use disorder information within health information exchanges, but they mandate data segmentation of diagnostic and procedure codes related to substance use disorders and restrict access only to parties with authorized consent, possibly adding barriers to the coordination and integration of addiction treatment with primary care.
OBJECTIVE: Title 42 of the Code of Federal Regulations Part 2 (42 CFR Part 2) controls the release of patient information about treatment for substance use disorders. In 2016, the Substance Abuse and Mental Health Services Administration (SAMHSA) released a proposed rule to update the regulations, reduce provider burdens, and facilitate information exchange. Oregon's Medicaid program (Oregon Health Plan) altered the financing and structure of medical, dental, and behavioral care to promote greater integration and coordination. A qualitative analysis examined the perceived impact of 42 CFR Part 2 on care coordination and integration. METHODS: Interviews with 76 stakeholders (114 interviews) conducted in 2012-2015 probed the processes of integrating behavioral health into primary care settings in Oregon and assessed issues associated with adherence to 42 CFR Part 2. RESULTS: Respondents expressed concerns that the regulations caused legal confusion, inhibited communication and information sharing, and required updating. Addiction treatment directors noted the challenges of obtaining patient consent to share information with primary care providers. CONCLUSIONS: The confidentiality regulations were perceived as a barrier to care coordination and integration. The Oregon Health Authority, therefore, requested regulatory changes. SAMHSA's proposed revisions permit a general consent to an entire health care team and allow inclusion of substance use disorder information within health information exchanges, but they mandate data segmentation of diagnostic and procedure codes related to substance use disorders and restrict access only to parties with authorized consent, possibly adding barriers to the coordination and integration of addiction treatment with primary care.
Entities:
Keywords:
Addiction treatment; Alcohol use disorders; Confidentiality; Drug use disorders; Public policy issues
Authors: K John McConnell; Anna Marie Chang; Deborah J Cohen; Neal Wallace; Michael E Chernew; Glenn Kautz; Dennis McCarty; Bentson McFarland; Bill Wright; Jeanene Smith Journal: Healthc (Amst) Date: 2014-09
Authors: Aimee N C Campbell; Dennis McCarty; Traci Rieckmann; Jennifer McNeely; John Rotrosen; Li-Tzy Wu; Gavin Bart Journal: J Subst Abuse Treat Date: 2018-11-19
Authors: Carlos Blanco; Tisha R A Wiley; Jacqueline J Lloyd; Marsha F Lopez; Nora D Volkow Journal: Transl Psychiatry Date: 2020-05-28 Impact factor: 6.222
Authors: Julia Ivanova; Tianyu Tang; Nassim Idouraine; Anita Murcko; Mary Jo Whitfield; Christy Dye; Darwyn Chern; Adela Grando Journal: JMIR Ment Health Date: 2022-04-20
Authors: George Karway; Julia Ivanova; Anweysha Bhowmik; Anita Murcko; Michael Saks; Dennis McCarty; Aimee Campbell; Maria Adela Grando Journal: J Addict Med Date: 2022 May-Jun 01 Impact factor: 4.647